Abstract

A series of novel quinoxaline derivatives linked to a pyridine moiety through phenylamino or phenoxy residue was synthesized and evaluated as candidate anticonvulsants. The synthesis was achieved through reaction of 2,3-dichloroquinoxaline (1) with an equimolar amount of 4-aminoacetophenone to give compound 2 which is considered as an important synthon for the construction of a pyridine ring via several synthetic routs. Some compounds were synthesized through formation of the intermediate α,β-unsaturated compounds which, in turn, were allowed to react with malononitrile to give the corresponding alkoxypyridines (8-17). Compounds 18-21 were synthesized by a one-pot simple reaction between 2, the appropriate aldehyde, and malononitrile in sodium alkoxide solution. Moreover, they can be synthesized through reaction of compound 2 and arylidenemalononitrile in sodium alkoxide. The phenoxy analogues were prepared by reaction of 1 with 4-hydroxyacetophenone or 3-hydroxybenzaldehyde to give 22 and 27, respectively. These compounds, in turn, were allowed to react with malononitrile and the proper carbonyl compound in presence of sodium alkoxide in a one-pot reaction technique to give the target compounds. Biological evaluation of the prepared compounds showed that some of them are potent anticonvulsant agents. The detailed synthesis, spectroscopic and biological data are reported.

Highlights

  • Despite the availability and optimal use of several antiepileptic drugs, 20-30 % of patients with epilepsy still experience inadequate seizure control

  • Many antiepileptic drugs have important structural similarities; the most common structural elements appear to be a nitrogen heterocyclic system with at least one carbonyl group and an aromatic substituent linked to the heterocycle

  • As a continuation to our previous work16on the synthesis of new quinoxalinederivatives and the study of their potential biological activities, we report in this paper the synthesis of a new series of 3-[4-(4,5,6-trisubstituted-2-pyridyl)-phenylamino]-2-0~10-2-dihydroquinoxalines 8-17, 3alkoxy-2-[4-(4,5,6-trisubstituted-2-pyridyl)-phenylamino]-quinoxalines 18-21, 3-alkoxy-2-[4(4,5,6-trisubstituted 2-pyridy1)-phenoxyl-quinoxalines 23-26 and 3-alkoxy-2-[3-(2,3,6-trisubstituted-4-pyridy1)-phenoxyl-quinoxalines 28-31 in order to ascertain which structural features and the attendant hnctionalities are necessary for their anticonvulsantactivities

Read more

Summary

Introduction

Despite the availability and optimal use of several antiepileptic drugs, 20-30 % of patients with epilepsy still experience inadequate seizure control. Several physicochemical properties, such as lipophilicity, have been associated with anticonwlsant action and are related to the ability of the drug to pass the blood brain-barrier in order to reach the site of action. The choice of these compounds appear interesting because there are some suggestions in literature that quin~xaline,~-p"yridine12-1a4nd aryloxyary115derivatives show remarkable anticonvulsant activity. Attempts were made to clarifL the situation and to test whether modulation of alkoxypyridine moiety could eventually lead to better anticonvulsantswith prolonged duration of action. As a continuation to our previous work16on the synthesis of new quinoxalinederivatives and the study of their potential biological activities, we report in this paper the synthesis of a new series of 3-[4-(4,5,6-trisubstituted-2-pyridyl)-phenylamino]-2-0~10-2-dihydroquinoxalines 8-17, 3alkoxy-2-[4-(4,5,6-trisubstituted-2-pyridyl)-phenylamino]-quinoxalines 18-21, 3-alkoxy-2-[4(4,5,6-trisubstituted 2-pyridy1)-phenoxyl-quinoxalines 23-26 and 3-alkoxy-2-[3-(2,3,6-trisubstituted-4-pyridy1)-phenoxyl-quinoxalines 28-31 in order to ascertain which structural features and the attendant hnctionalities are necessary for their anticonvulsantactivities

Results and Discussion
24 CCl-Ph
Synthesis
Anticonvulsant Screening
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.